Evidence map›Paper›PMID 32324807›Full record

ArticlePLoS pathogens2020

Non-pathogenic Escherichia coli acquires virulence by mutating a growth-essential LPS transporter.

Chikara Kaito, Hirono Yoshikai, Ai Wakamatsu, Atsushi Miyashita, Yasuhiko Matsumoto, Tomoko Fujiyuki, Masaru Kato, Yoshitoshi Ogura, Tetsuya Hayashi, Takao Isogai and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Activation of GABAAntioxidants (Basel, Switzerland) · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Knockout ofJournal of bacteriology · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Animal infection models using non-mammals.Microbiology and immunology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 1 country.

Chikara KaitoGraduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Kita-ku, Okayama, Japan.ORCID 0000-0002-2895-3386
Hirono YoshikaiGraduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
Ai WakamatsuJapan Biological Informatics Consortium (JBIC), Koto-ku, Tokyo, Japan.
Atsushi MiyashitaGraduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.ORCID 0000-0002-9076-0569
Yasuhiko MatsumotoDepartment of Microbiology, Meiji Pharmaceutical University, Kiyose, Tokyo, Japan.
Tomoko FujiyukiThe Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.ORCID 0000-0001-5533-4129
Masaru KatoDevision of Bioanalytical Chemistry, School of Pharmacy, Showa University, Shinagawa-ku, Tokyo, Japan.
Yoshitoshi OguraDepartment of Bacteriology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.ORCID 0000-0002-4509-2653
Tetsuya HayashiDepartment of Bacteriology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Takao IsogaiTranslational Research Center, Fukushima Medical University, Fukushima, Japan.ORCID 0000-0002-1970-4556
Kazuhisa SekimizuInstitute of Medical Mycology, Teikyo University, Hachioji, Tokyo, Japan.
The University of Tokyo · JPKyushu University · JPFukushima Medical University · JPJapan Biological Informatics Consortium · JPMeiji Pharmaceutical University · JPOkayama University · JPShowa University · JPTeikyo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The molecular mechanisms that allow pathogenic bacteria to infect animals have been intensively studied. On the other hand, the molecular mechanisms by which bacteria acquire virulence functions are not fully understood. In the present study, we experimentally evaluated the evolution of a non-pathogenic strain of Escherichia coli in a silkworm infection model and obtained pathogenic mutant strains. As one cause of the high virulence properties of E. coli mutants, we identified amino acid substitutions in LptD (G580S) and LptE (T95I) constituting the lipopolysaccharide (LPS) transporter, which translocates LPS from the inner to the outer membrane and is essential for E. coli growth. The growth of the LptD and LptE mutants obtained in this study was indistinguishable from that of the parent strain. The LptD and LptE mutants exhibited increased secretion of outer membrane vesicles containing LPS and resistance against various antibiotics, antimicrobial peptides, and host complement. In vivo cross-linking studies revealed that the conformation of the LptD-LptE complex was altered in the LptD and LptE mutants. Furthermore, several clinical isolates of E. coli carried amino acid substitutions of LptD and LptE that conferred resistance against antimicrobial substances. This study demonstrated an experimental evolution of bacterial virulence properties in an animal infection model and identified functional alterations of the growth-essential LPS transporter that led to high bacterial virulence by conferring resistance against antimicrobial substances. These findings suggest that non-pathogenic bacteria can gain virulence traits by changing the functions of essential genes, and provide new insight to bacterial evolution in a host environment.

Indexed as

AnimalsBacterial Outer Membrane ProteinsBiological TransportBombyxCell MembraneEscherichia coliEscherichia coli ProteinsLipopolysaccharidesModels, MolecularProtein BindingVirulenceBacterial Outer Membrane ProteinsEscherichia coli ProteinsLipopolysaccharidesLptD protein, E coliLptE protein, E coli

Identifiers

PMID32324807
PMCPMC7179839
OpenAlexW3020350461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.